2015-08-18 17:35:03 |
ASX Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e1382799f89fb785636e20490c135c5 |
|
2015-08-18 17:42:52 |
ASX Admission Market Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9f2b6e2dafda173778c4155cc9cb4fed |
|
2015-08-18 17:49:51 |
Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/770c1f866fd1fc94ee709a322a0a0e9c |
|
2015-08-18 17:50:24 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19da0055a2f4bc1d8895d2859bc3b862 |
Company Administration General
|
2015-08-18 17:52:58 |
Appendix 1A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c76557d03ff02c2c3352e3df140de65 |
Stock Exchange Announcement Ge
|
2015-08-18 17:54:59 |
Information Form and Checklist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07d7f70a87bbbe25b8b34c0e43fa07ca |
Company Administration General
|
2015-08-18 17:55:24 |
Financial statements for period from 2 May to 30 June 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27def39ddcd7e50b88413289ae06a913 |
|
2015-08-18 17:57:15 |
Financial statements from 1 July 2014 to 31 March 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49642906ac7844e4a05d5cdcc09c0394 |
|
2015-08-18 17:57:36 |
Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33343cbc0751e8b99c35191bd741e0d0 |
|
2015-08-18 17:57:58 |
Top 20 Holders List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd82b6196aee2b5048d43494e19b729f |
|
2015-08-18 18:00:50 |
Corporate Governance Policies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1a9eec9d76d475c8afefe66f22da851 |
|
2015-08-18 18:01:25 |
Pre-quotation disclosure |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70482e0ba0947d7f930d9d3f01e9243b |
Company Administration General
|
2015-08-21 16:08:22 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7188bfd128d37f948299b867be02d842 |
|
2015-08-21 17:18:36 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d48fea7101088c266c05aa90d99d4f8 |
|
2015-08-21 17:18:51 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7d5c1d693b4a26cdca3ed817836bbe7 |
|
2015-08-21 17:20:07 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72af2d3a677ec4efa35bbed9cb18ee35 |
|
2015-08-21 17:27:17 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32434dcda59b717977107f2f948ade21 |
|
2015-08-24 09:31:06 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1eacba13277116741547e19118f35165 |
|
2015-08-24 09:31:30 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c5d818eb464716af4d7eda57b67fbd2 |
|
2015-08-24 09:46:08 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d24f71977e2db222c8ba1553963efae7 |
|
2015-08-24 11:31:53 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ce10b8e86a0a681bf6526b72ac27e6b |
|
2015-08-26 09:59:36 |
Paradigm Secures Key US Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7f7396288e5bcf745b0ad7a70fad477 |
|
2015-08-31 15:39:02 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89f1669024cf6113e7f4097ddf9eab30 |
|
2015-09-28 11:13:26 |
2015 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04f077f73305dbd922de27faeb21dd2e |
|
2015-09-28 11:19:27 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2efd06138447c15fec5490497f6b4313 |
|
2015-09-28 11:29:35 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2527e1fbc63760790b42b9f6645b2df7 |
|
2015-10-22 14:02:09 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/172853f8ba6e016b4b1ad7d7a255afcc |
|
2015-10-28 11:48:55 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07a13c1533440bce56b0c91382d4fdcf |
|
2015-10-30 11:03:45 |
CEO AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e59de5e48689bd25c64def8acea17cc |
|
2015-10-30 15:38:51 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e99639a95b1a85bf8989bbe88b136e14 |
|
2015-11-10 13:41:47 |
Appendix 3B - Release from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e28f28e19034fadbc05aa46be090718 |
|
2015-11-23 10:45:32 |
Paradigm Biopharmaceuticals Receives Ethics Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f0f8c7d8e1cab957a6d952283a9f3bb8 |
|
2015-12-03 09:52:36 |
Elite Athlete successfully treated with Paradigms Zilosul |
1 |
https://app.sharelinktechnologies.com/announcement/asx/df2a2f8e610d0f4b9106065ef2649d09 |
|
2015-12-14 17:16:25 |
Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0560bba54996e15f96de1bb484cf1a1d |
|
2015-12-15 09:19:27 |
European Patent Office Grants PAR Key Respiratory Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb6a15350fd77e22e72729c7763bd88c |
|
2016-01-27 11:42:49 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c30be77713557981daa9de043d9da53 |
|
2016-02-23 09:08:49 |
Paradigm starts Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/58c6de72f6e538831163799b7c59c0f2 |
|
2016-02-25 08:41:59 |
First Participant treated in Paradigms Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e13a55c62b7dff756fe55daf6f2f4e3e |
|
2016-02-25 14:15:33 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65309d63d5a89fbea28642f94b6f1a6a |
|
2016-03-02 08:36:09 |
Paradigm initiates second clinical trial site |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d434314649ec29b5bcc595553ab1695e |
|
2016-03-15 19:21:18 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae22b078adb4d25d9d17c872d02f8a52 |
|
2016-03-15 19:25:20 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e39b9612d1f6dcd5dcf4341191302c8 |
|
2016-03-16 09:10:51 |
Paradigms Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55085eaf3edb48a716f65a4fb7e835e7 |
|
2016-04-14 14:54:54 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c845f5581ba6810deaf970d5ad19fb06 |
|
2016-04-21 10:33:42 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19606517de7bff69f6a26a9dbf78fa2f |
|
2016-05-09 14:17:57 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c642be007501a1d87448f28fc8778c9b |
|
2016-05-25 10:21:30 |
Investor Update Hayfever Allergic Rhinitis |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a94736db06e88466f27d17acb3dbf293 |
|
2016-06-09 09:55:55 |
Shareholders Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/989ba42ba38eca5b448eb05ed444bff4 |
|
2016-06-09 09:57:04 |
Baker Young Stockbrokers Initiates Coverage on Paradigm |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b0c14b6ae35986fb49517069f68118f |
|
2016-06-20 09:26:59 |
Investor Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b477fd98e16c62bf630728f6ecdc4e47 |
|
2016-07-21 16:24:52 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f809ef4fe6d0ebca72c7693bae212cd |
|
2016-07-28 17:37:46 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2151a8d7804efa8624bb7a78e249bbf2 |
|
2016-08-12 14:29:31 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0b2d34db0aee439ea15b1a4f23e2369 |
|
2016-08-19 09:42:17 |
Paradigm PPS nasal spray to treat Allergic Rhinitis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d20141491665bd27056ca8e836da9519 |
|
2016-08-31 16:57:37 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d79e9f55f079ca1b2524df28b3058cb |
|
2016-08-31 17:02:56 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa6e3bf4f30f964b5ce4e026be5cade5 |
|
2016-08-31 17:05:06 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e18a0769b77e336c8d7a833c32e6c9b6 |
|
2016-09-07 08:51:12 |
Paradigm PPS a potential in the treatment of viral arthritis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4b8cf250ada40d48bee6596e96eb798 |
|
2016-09-13 11:37:02 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5877f32a292c4384254d2340847eba7 |
|
2016-09-16 09:07:31 |
Preclinical study underpins efficacy of Paradigms RhinosulR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/918f300d9283202be9664f563780bec0 |
|
2016-10-12 12:45:42 |
Paradigm Biopharmaceuticals updated corporate presentati |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3b4c456b4c0c9f00911355a8a251f47 |
|
2016-10-14 09:34:31 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ace7b243fb6b0692c7e21258deeab2a7 |
|
2016-10-18 09:14:47 |
Paradigms Placement heavily oversubscribed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa330140bff4d7959c5ead46f8df230e |
Stock Exchange Announcement Ge
|
2016-10-21 09:18:38 |
PAR Share Purchase Plan 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49da3a4efddd2398734cdfb8e92d5996 |
|
2016-10-28 09:59:39 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd96ac5afa75f30c8335d1b5d267b528 |
|
2016-10-28 11:50:45 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97bda270523d44d62ba4cd27b6eb210d |
|
2016-10-28 12:15:32 |
Appendix 4C - September 2016 quarter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/35fe7dc4a662790d46d1756d8a69928d |
|
2016-10-28 16:37:21 |
Cleansing Notice - Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e58ae48c1ade6b6b010a9c9c50635c98 |
|
2016-11-17 12:22:52 |
PAR Share Purchase Plan 2016 - Extension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4644cebdd1cacc230e2e507f07ac8221 |
|
2016-11-22 09:18:46 |
Paradigms hay fever clinical trial cleared to commence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c49fb92afa87503fbcbee5be29a37cd6 |
|
2016-11-30 09:28:24 |
Managing Directors Presentation to AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/801a1641fe4dcaac402af34f0c3051fc |
|
2016-11-30 12:40:52 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0d7cbb8128fc4d9b9bcac4f186b91d0 |
|
2016-12-02 16:35:17 |
Closure of SPP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ea6716c1616643024032b8957f2e3a4 |
|
2016-12-09 09:17:37 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e69ccc138e768b36d4bbe29d1fc7792a |
|
2016-12-09 09:19:31 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ccd85b701f2b1bf6f2ed23fb068ab3a |
|
2016-12-09 09:24:14 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c011262637de6cdc3108c9f750d5f6a |
|
2016-12-09 17:38:22 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae70b1ed068f3a86174fbbec2e35d853 |
|
2016-12-09 17:40:34 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e47957da4a0b029cf3bde1b41702f18a |
|
2016-12-15 11:29:22 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c7a25c0a88dbe1d309c971d94912749 |
|
2016-12-16 12:29:56 |
Broker Initiated Coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ef45eae4e1cf21dfddc74a09ed6a889 |
|
2017-01-19 10:01:27 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8c63eb1f66a80d46a79b12bab17099c |
|
2017-01-20 10:42:33 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a1ae9b045a2070d9156990974abcd7b |
|
2017-01-25 09:14:41 |
Recruitment complete in Paradigms hay fever clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa767b2fb5be433b771cbb90090532e2 |
|
2017-01-31 14:56:39 |
Quarterly Cashflow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eadf344345cffbb65cadf1ffdd43d6d6 |
|
2017-02-07 16:07:04 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49924bc46bb2b44382e6cd63a5b0db7c |
|
2017-02-24 17:10:50 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b636c4dfe869d578f196ceaea6c404b |
|
2017-03-02 09:37:42 |
Broker Research Report for Paradigm Biopharma |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90bcb05ef5ac3a0659b72f9ea75da7be |
|
2017-03-07 13:47:52 |
Paradigm Update Ross River Virus Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/efcdc22e70bc33cfe6a61c3b96cbb7cf |
|
2017-03-21 09:15:36 |
Paradigm Presents to Asian Investors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d6fed2764a3a80830b61e40b4fc5a91 |
|
2017-03-22 09:25:18 |
Paradigm receives $1.34 million R&D tax incentive rebate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd8fc92d56eb21aeb591410a6bd59960 |
|
2017-03-23 09:12:21 |
Final participant treated in Phase 2 hay fever trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/150adde2a8a017a2bf9b4577465f6ef1 |
|
2017-04-28 09:37:33 |
Paradigm March Quarter Update & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a8e2609180532536bdc556633983a28 |
|
2017-05-11 09:28:57 |
Paradigm Government grant for Ross River virus research |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80229668539ce2a4d6039b01be2c7a94 |
|
2017-05-15 16:36:00 |
Paradigm Non-Deal Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d69fe218fc95325cb1d75de033b646ae |
|
2017-05-16 08:29:19 |
Paradigms preclinical hay fever trial published |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5a4b5eec8ac6f171ae8443ef89805cc |
|
2017-05-22 08:43:37 |
Paradigm Receives Ethics Approval for Ross River Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2374e23bb04b1aefa7490c8067cf6bdd |
|
2017-06-15 09:01:49 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5410db88d13bbd84f8a059faa19a7cbc |
|
2017-06-16 09:00:35 |
Hay Fever Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/736b1bfc3473792bc1c3353113d98045 |
Stock Exchange Announcement Ge
|
2017-06-19 15:38:52 |
Q and A on Hay Fever Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc13572487548359242752af4c78641c |
|
2017-06-20 08:59:40 |
Paradigm Enters Heart Failure Market |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83ca26d3486744b6c2c05fd2bdcd91e3 |
|
2017-06-26 10:13:07 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87325e1562fb96339388ed097c2a94e4 |
|
2017-06-28 09:35:11 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e4280296c6104cb6dbfdc4b13080456 |
|
2017-07-04 17:53:30 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66ec99e49a92a5c96bea29cee55b0e08 |
|
2017-07-10 08:28:04 |
Paradigm To Commence Phase 2 Ross River Virus Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5f33877c73c1a98b6a0a1379e5c14d4c |
|
2017-07-28 09:22:49 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5fcc585dec27270518e3e54a8ccee01f |
|
2017-08-03 14:00:10 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32f575f50fa988857590de4847929999 |
|
2017-08-09 09:20:57 |
Paradigm (PAR) - First Ross River Trial Participant Treated |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b266e065a199585515769dccc40f20f |
|
2017-08-21 09:28:58 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbc71574a989a0d6a092ef8367ab1744 |
|
2017-08-29 17:35:43 |
Appendix 4E and 2017 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c632abfd029e0b7f1dafb491755ff2bc |
|
2017-08-29 17:38:08 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f3f33b128b8765b3d63d256e14d8418 |
|
2017-09-11 08:37:56 |
A PARADIGM SHIFT IN TREATING OSTEOARTHRITIS PAIN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ec3beae3688ca4deed627bdc2b7552c |
|
2017-09-14 09:29:33 |
Paradigm Phase 2 Ross River Virus Clinical Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbc2b6d3c692636af32a03f6f95b05c9 |
|
2017-09-19 08:34:30 |
PARs Osteoarthritis Phase 2 Receives Ethics Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e3532dbda23981fd955299429e7207e |
|
2017-09-28 12:17:22 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de2542bd429d32ead875dc5078ff2495 |
|
2017-10-10 09:12:09 |
PAR REPORTS PAIN REDUCTION IN 83% OF OSTEOARTHRITIS PATIENTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/905eba5bc8b5cfc1e7f110632ef27596 |
|
2017-10-10 16:41:36 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/894413b0c604ab0ed1147d80aa0f7d8b |
|
2017-10-11 10:08:32 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7a4287c7be4126617a22ebd0b10b38f |
|
2017-10-30 08:39:30 |
First Participant Dosed in PARs Phase 2b OA Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f95609abfd037b904c5dfd51399d5a62 |
|
2017-10-31 16:18:02 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/369f7e3e2201201305a89f87482f87ed |
|
2017-11-02 08:28:15 |
PAR Updated Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef0ef95145e2667dcb589ca02111efbd |
|
2017-11-02 08:53:30 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbe0f7ba513dac5349077935c6733779 |
|
2017-11-06 09:30:03 |
PAR Successfully Completes A$5.75m Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/52bea33d7c69cfd75e5e696ec22ba589 |
Stock Exchange Announcement Ge
|
2017-11-10 10:01:39 |
CEO Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ce19891196149d0a2d4a3a67456f2d8 |
|
2017-11-10 12:40:41 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d23b90914cba64b269d5c0cbbffbc92f |
|
2017-11-13 16:56:52 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59d1358481a51e240fe42ae2551a301c |
|
2017-11-14 08:38:35 |
Paradigms ACL Phase 2 Clinical Trial Success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd2ddb1bc244683ad16f3cd0cf56189e |
|
2017-11-15 09:46:50 |
Cleansing Notice - Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0af2196053914a9546fed487ef8cf381 |
|
2017-11-15 11:03:41 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c52a6cf085d616b862b8eafbe92d5e4 |
|
2017-11-15 11:10:01 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/986ea7b88090209786b491c6b71fcaa8 |
|
2017-11-16 17:12:19 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34f00dfbad3e45007b7ff7d102e3541d |
|
2017-11-23 08:27:40 |
Paradigms Two Arthritis Phase 2 Clinical Trials on Schedule |
1 |
https://app.sharelinktechnologies.com/announcement/asx/004a60a94b20d7a805f0b2d2b45d5569 |
|
2017-12-20 13:55:09 |
Paradigm Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df558cca0fe98b151d54f364707033dd |
|
2018-01-16 08:31:14 |
PARs European Patent Granted for Bone Marrow Edema Lesions |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44453bbc02541db0d7cea4a7ed5a4bc6 |
|
2018-01-24 09:55:56 |
Elite sportspeople successfully treated with PPS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edb81418cc1ed5663a521a1eae401d24 |
|
2018-01-30 10:30:24 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e36b351b6d77d0270951bc17be5597d |
|
2018-02-22 17:30:14 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e927b8539bc2b3c70fc8c02c840b99f |
|
2018-03-01 08:18:38 |
PARADIGM REPORTS OSTEOARTHRITIS PAIN REDUCED BY 50% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3c6ebd74d2946dc7580719368770e27 |
|
2018-03-27 10:05:17 |
PARADIGMs PHASE 2 CLINICAL DATA UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a2e7a3a39eef4965f6ad3ebc3faafc8c |
|
2018-04-13 17:25:11 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7b9d67e85773f125e9f87a37aadf6fa |
|
2018-04-17 09:38:20 |
PAR Non-Deal Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03e18cca95984fb96ba4dbdec384f0e2 |
|
2018-04-30 08:21:33 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbf33f80a8103a62b892aa9f3cffeefb |
|
2018-05-07 19:04:14 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81971f3aeb8b7882bc696fbaa7d116c4 |
|
2018-05-08 09:59:29 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcda387df1f4226eadc17306850c0e4b |
|
2018-05-08 14:02:35 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a63932a72a703f41a1fb5ad1b5dab580 |
|
2018-05-17 08:56:51 |
Paradigm OA Phase 2b Clinical Trial over 80% Recruited |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4de89695d9ebfddd05a90075ff78c641 |
|
2018-05-18 17:06:05 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42e4bf190a12930b8993cc4d43150406 |
|
2018-05-18 17:07:30 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fd9044688036c94df71f7541e88b892 |
|
2018-06-15 08:29:46 |
PAR - 50% REDUCTION IN OSTEOARTHRITIS PAIN MAINTAINED |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc022812018817a397fe3052047bdb61 |
|
2018-06-19 16:25:32 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5974a298b8bf35ef00267878bd283da3 |
|
2018-06-26 16:24:57 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be569de94f9774251d80ea9391096ac0 |
|
2018-07-04 17:18:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/286c103062ab2534c20d32cd24a08929 |
|
2018-07-09 09:06:01 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c93482b4188196ae1afdd8eac62e39af |
|
2018-07-17 17:17:56 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87328a77e75060f4b03227b13eab5ff3 |
|
2018-07-27 15:52:21 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4367aa8dd83e694f6bbbbd110f7067a0 |
|
2018-07-27 16:03:11 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d3784f7aabbfd8de8d0195383ddc5f8 |
|
2018-08-06 09:16:10 |
PAR achieves 100 per cent recruitment in Phase 2b OA Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49740bd0c31b57cb4182305af004c375 |
|
2018-08-08 16:39:20 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4b9fede1aa1bd73f9472efade3330f7 |
|
2018-08-15 08:09:40 |
PAR ACHIEVES 60 PER CENT REDUCTION IN OSTEOARTHRITIS PAIN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0f9711c9e65e69c63637fe1f98e7978e |
|
2018-08-24 16:20:52 |
Appendix 4E and 2018 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42393c806709aa35b69ada654fd60a34 |
|
2018-08-24 16:25:32 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6f30940fba7eedab55d81fe4868ee6d |
|
2018-08-28 12:04:27 |
Phase2a RossRiver Virus Clinical Trial Recruitment Finalised |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc7808ecc7f9077ffc33be2e645ef258 |
|
2018-09-25 08:28:29 |
PAR REPORTS PAIN REDUCTION IN OA PATIENTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f16fa109c9f948f0d25fe60c5115c74e |
|
2018-10-23 09:15:46 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/555b2790297dac08e15d976fe71e4a87 |
|
2018-10-25 08:57:19 |
Paradigm Raises A$9 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad632bb3e97f46b39549bfad3ff8b207 |
Stock Exchange Announcement Ge
|
2018-10-25 08:59:19 |
Paradigms Updated Corporate Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89622cfbab26ff3d94c341959ed2bbd2 |
|
2018-10-25 09:02:09 |
Paradigm Agreement With USA Past Players Network |
1 |
https://app.sharelinktechnologies.com/announcement/asx/29a696578f83eac0aaea810c594d1fb6 |
|
2018-10-26 16:49:53 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c8232243ed5bafea6400f9d6de9a2f2 |
|
2018-10-31 09:27:39 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/214ba205068027560cf3b6ffaa795723 |
|
2018-11-01 12:14:43 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7f92a5061fecc25efe5041728234683 |
|
2018-11-07 11:00:31 |
PAR reports pain reduction in 145 people with osteoarthritis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f28165d91a022e8f60aa0af8c3c92e8c |
|
2018-11-15 08:29:21 |
PARADIGM RECEIVES $2.32m R&D TAX INCENTIVE REFUND |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5fd9ceea125e5ad48e3cdf90dfbfbb12 |
Company Administration General
|
2018-11-22 08:29:51 |
Paradigm in-licenses treatment for rare joint disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3bb6ef094ab461fd9f6f6ce6d993bef3 |
|
2018-11-26 12:29:52 |
Paradigms AGM Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/592645158795c990da6e388f6bc5df87 |
|
2018-11-26 17:12:28 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e469d92e778dbf670eb0796ce08294a |
|
2018-11-27 15:34:50 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f58a31159d9cb3f4e6a1016f7968f5c0 |
|
2018-11-30 20:20:32 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c086ffc19f64b05b9970c327679543f |
|
2018-12-07 08:30:59 |
PARADIGM REPORTS CONSISTENT OA PAIN REDUCTION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2db3f92235a51a2bb30f0750c7741b1c |
|
2018-12-13 13:44:16 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d026400b7d12e9fe677e6e19bffb9a53 |
|
2018-12-13 13:47:26 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0e352e3b21c5afe3db8b27118235175 |
|
2018-12-13 13:49:16 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1f16ea3bc4349569afe41e1e8f5beea |
|
2018-12-14 08:46:02 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04cc55d07861f62ad65886309a186711 |
|
2018-12-17 11:30:30 |
PAR - Conference Call Details - Phase 2b OA Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/758896ce130e5936f26bb1759c656f5b |
|
2018-12-18 08:47:36 |
PAR REPORTS SUCCESSFUL PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c313286ad537ba89b34aafa4361fc262 |
Stock Exchange Announcement Ge
|
2018-12-18 08:48:11 |
PRESENTATION OF PHASE 2 CLINICAL TRIAL RESULTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27312e82e9dc22ef15b59620facd25c7 |
|
2018-12-20 08:40:20 |
PARADIGMS SUPPLEMENTARY PHASE 2B DATA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/404393e8efca667ecbe7af7aed9825e6 |
|
2019-01-31 16:52:41 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/01ae5a8348b4aa6d11a68d11c54c53ee |
|
2019-02-14 09:41:13 |
PARADIGMS ORPHAN PHASE 2/3 CLINICAL PROGRAM PROGRESSES |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a20fa8b0033556de57a4e29624785077 |
|
2019-02-14 17:25:45 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/439732f29f8767a91c5d06d7f7417a9f |
|
2019-02-21 18:17:09 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5824ebb9e2e8d5d40441ab7d586e7a67 |
|
2019-03-08 08:22:22 |
S&P DJI Announces March 2019 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e33e1ae1418ec56c6d8862724ac228da |
|
2019-03-08 14:30:29 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d377d0a5570156e80ecbb33d8197ebbc |
|
2019-03-13 08:41:32 |
Paradigm (PAR) Updated Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a688ae0a6c1d8779b859200aeb7152f |
|
2019-03-28 08:59:09 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72e10e4d35d569461acfaca3885071ef |
|
2019-04-11 09:04:46 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9027ce669e9165857233137e59bd763d |
|
2019-04-15 09:14:34 |
PARADIGMS SECONDARY ENDPOINTS SUCCESSFULLY MET |
1 |
https://app.sharelinktechnologies.com/announcement/asx/863f9a5a7e60a7e9a378ee2913cb4592 |
|
2019-04-15 09:15:49 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a3b8e72374fe539c6324d6b3081f094 |
|
2019-04-15 09:17:39 |
Cleansing statement under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca957ed8f6d1c708ac4738186b238c34 |
|
2019-04-15 09:21:29 |
PARADIGM LAUNCHES A$77.9M CAPITAL RAISE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d2067c5ffcfe13216e889b3d58cf4bf |
|
2019-04-15 09:29:44 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1fc6c69101c6d2833c08f860582d21b0 |
|
2019-04-15 09:31:09 |
PARADIGM UPDATED CORPORATE PRESENTATION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b88042f63c7c33c0446b996ad360534b |
|
2019-04-17 08:58:29 |
Paradigm Confirms Capital Raise Commitments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56b0f25c4cbf65ca3320ae0b4cf7bc1a |
Stock Exchange Announcement Ge
|
2019-04-17 09:00:19 |
PAR Accelerated Non-Renounceable Rights Issue Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bff13639d69dd21fb72e1f6a3d5df742 |
|
2019-04-23 16:43:57 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac0b3aef652156c25b116a6f0ffddcda |
|
2019-04-24 08:26:21 |
Cleansing statement under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2df10ce6b348f920f60c5c83aa6092c0 |
|
2019-04-24 09:39:02 |
Completion of Institutional Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee957e3a27ac474ca9e59fdf0c2d816e |
|
2019-04-26 09:05:05 |
Cleansing Notice under section708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b780b0e2e318f15fbdbcb825872af82 |
|
2019-04-26 09:06:25 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22a7ec26145559aeacd69b01429ee2f1 |
|
2019-04-30 11:41:24 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a654d77b5b91857f4638c9fc8e0535b |
|
2019-05-08 08:23:04 |
Paradigm Corporate Update - May 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d8bca6f97e6cacf4f4182b19d7127cf |
|
2019-05-09 08:23:12 |
Successful Completion of Retail Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3177952b45f2795ad5f4ee3321885b81 |
|
2019-05-13 08:36:52 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4bb25453833cd9b1f17f02582fa4c52 |
|
2019-05-13 09:45:53 |
Updated Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3999f93f7f06888b98ea95614b530c8a |
|
2019-05-21 11:40:07 |
PAR CORRECTS AFR ARTICLE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/225eea1d8882da6c4e3b1d8ac9831525 |
|
2019-05-28 08:24:21 |
PAR reports consistent pain reduction in knee OA of patients |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a4b510b3d975cb2fe0801c2c0cfe59e |
|
2019-06-04 08:31:21 |
PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c00b273f7950d4b73a392da32100567 |
|
2019-06-28 13:10:01 |
Paradigm EOFY Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90bb03d7e160861b9bf1ce0a5644c599 |
Company Administration General
|
2019-07-02 09:46:13 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e0d61508eeea161646a0731f1a624ce |
|
2019-07-02 09:51:23 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3684ae1227b6e0e02e0c9a5a95b7f9b |
|
2019-07-03 09:36:19 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/080536988f8ac67105240cb4aa33956e |
|
2019-07-05 09:18:18 |
Response to ASX Appendix 3Y Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/246842af21165061700670d48406442e |
|
2019-07-31 11:40:07 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/565f1b272488451e5890585deada92e2 |
|
2019-08-07 09:37:56 |
PARADIGM FILES FIRST IND WITH US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c958428ccc0fe66494ff82098d34d0bd |
|
2019-08-29 08:27:04 |
PARs drug reduces cartilage degradation in subjects with OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b301dbf4496297f6966c41cd88daf74 |
|
2019-08-30 12:50:47 |
Appendix 4E and 2019 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/69c7e55d3f44a7eda8f8667e3b519ea1 |
|
2019-08-30 12:51:42 |
Appendix 4G and 2019 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54c49e925ebf070879c3cacdf5b31d98 |
|
2019-09-10 10:32:31 |
PAR Expanded Access IND Cleared by US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e91ad67b0edfc0df34e7bf7f851531a5 |
|
2019-09-12 16:07:45 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9e01b106254640d3ce2590e97b1c7b1 |
|
2019-09-17 11:24:48 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e618350ebbe9e71feffabf5929257d2 |
|
2019-09-24 17:13:50 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d01528a51b396406972f0de46346005e |
|
2019-09-30 08:13:52 |
Osteoarthritis pain reduced by Paradigms Zilosul (PPS) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51b335721a66d3541187835edbccab96 |
|
2019-10-01 16:20:50 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a60439f635ca4d41bb4114417af3f1b |
|
2019-10-04 11:16:29 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01aeaf201b1f4c3a5363faae506d884a |
|
2019-10-22 17:03:46 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3400f2afbbf88deeeb2d3ae84e0e4ba3 |
|
2019-10-25 08:21:19 |
PARADIGM PROVIDES REGULATORY FILING UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/562e99ae957afe0a433e32dbbd9840de |
|
2019-10-31 10:11:10 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c56999001a22c264e1db7a5d02afa6a |
|
2019-11-07 10:47:44 |
Paradigm AGM Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44963f008169ec6c9be9156d6085ca85 |
|
2019-11-07 18:05:36 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1af57c82c74df181fa6c7695da82e747 |
|
2019-11-11 11:27:02 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d352230cdce059a455034fbc2e5693b3 |
|
2019-11-14 20:05:51 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62d59fa6cad410c72049707d4d2afc0b |
|
2019-11-14 20:11:01 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ec02f3a4b81c60325d63c6691a528e3 |
|
2019-11-19 16:21:06 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa6dd803b7b21ca311a1074fa28c4244 |
|
2019-11-25 16:04:38 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/218e367a0bffadd806fd369e48a02575 |
|
2019-12-04 08:41:28 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5680c91a5c9a22aff121f5140ce7beb4 |
|
2019-12-04 08:43:28 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60f558ceefe21dad1ba5f3e9841da3b4 |
|
2019-12-12 08:21:12 |
Paradigm End of Calendar Year Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd8a0489137db03d1d543665666d3902 |
Company Administration General
|
2019-12-13 16:51:22 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f3eebb465378fe28e1ab0b241dec2a9 |
|
2019-12-18 17:49:59 |
Cleansing Notice and Appendix 3B |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c09e911037726558e11fdc85e1dba789 |
|
2020-01-14 16:22:39 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/267132379b3afb5e795669c09d182fd3 |
|
2020-01-14 16:24:54 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ddf36225de96e36b150f67ed1d65ade |
|
2020-01-15 16:18:21 |
Updated Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b87954a2707d56a740bb3eca62c80ae |
|
2020-01-31 14:42:17 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/568cf6e63474ed2e0b835bb18c2293f9 |
|
2020-02-03 16:40:37 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5e9b06d7cb724eeefa67152ff99ada6 |
|
2020-02-10 17:17:44 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7315af4b43faa2404cad7559191d86b |
|
2020-02-13 08:28:26 |
Paradigm presents MPS VI poster at WORLD Symposium |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39817f7cd617989612535baac3452b58 |
|
2020-02-14 16:27:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9000d403f40714ff4e53f5c18c286852 |
|
2020-02-18 09:12:47 |
Paradigm - first patient dosed in USA under FDA approved EAP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ce0fa22ff17cd6b44c822541ada4cdf |
|
2020-02-21 08:16:25 |
Paradigm reports Positive Pre-IND meeting with US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63ed368c71a582e65dec0ed1c81e7846 |
|
2020-02-28 16:35:56 |
Appendix 3B and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b56ab0f3b345954f6dfe6d3ed476e3c8 |
|
2020-03-16 13:48:39 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a388c86478664a79c1462e7a7e61443 |
|
2020-03-16 13:51:04 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cf78610e0c676d903cbf42b05462899 |
|
2020-03-24 08:22:01 |
All 10 participants in US FDA EAP have commenced treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57e07cea84d9ae330ff216e84dd316bf |
|
2020-03-24 08:38:01 |
Paradigm to present at Virtual Conference, Friday 27th March |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3a1186ccfc6f05eb59c4859cf744df6 |
|
2020-03-24 16:37:08 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b2e5e7e1215b6f3938ff825bd1a1397 |
|
2020-04-02 09:21:30 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4ec0e9b6b1bcec21a93c3bd350c4cbe5 |
|
2020-04-06 11:54:11 |
Voluntary Suspension |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb9985c3af6becfff76bac5cb9ed7fd0 |
|
2020-04-06 12:21:56 |
Paradigm Latest Corporate Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/098bc1de5163360aca8cb9888b467298 |
|
2020-04-06 12:48:56 |
Paradigm receives clarity on US regulatory pathway |
1 |
https://app.sharelinktechnologies.com/announcement/asx/37a4e100b3130799fd96d6dcf69ddb6f |
|
2020-04-06 13:07:36 |
Paradigm Reports Very Encouraging Real World Data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a21948426f0879a1cd040ac78d4e329 |
|
2020-04-07 15:49:39 |
PARADIGM TO HOST INVESTOR CALL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca550a55b5cf07684c336c25e088f1dc |
|
2020-04-08 10:52:26 |
Proposed issue of Securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eff7fecf833c0f4f40dcad63d19904be |
|
2020-04-08 12:23:21 |
Paradigm completes $35m raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e969e8df02d06983844e8ea63e3a8048 |
|
2020-04-08 12:23:36 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/743f5f65224ee078dc50a1e290393290 |
|
2020-04-16 09:29:55 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a8d0e5bb13786a2c8d18827cd911f87 |
|
2020-04-28 08:41:28 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b81a576f4589f64dbdfcf2cfd476a8aa |
|
2020-04-30 10:24:43 |
EAP treatment completed and Orphan Status achieved for MPS-I |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65f17acf6bc4109f5e5af485c5682562 |
|
2020-05-12 11:31:19 |
BLOCK TRADE TO INSTITUTIONAL INVESTORS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49827de196e2fb4cf8b676271891a731 |
Company Administration General
Security Holder Details Genera
|
2020-05-12 11:36:24 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c69ad814918eb9a443bbab3550ced84 |
|
2020-05-12 11:41:04 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/399c5e844e7289f8f41b4a0d978eac56 |
|
2020-05-12 11:43:34 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/407b357fcf9c838771edc261d7be0214 |
|
2020-05-12 11:50:24 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9b20920472d824d68a181f8bbb9fefd |
|
2020-06-03 08:19:47 |
Paradigm Further Strengthens Senior Management Team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9c2741245869d7a35161ac3805ddb94 |
Company Administration General
|
2020-06-12 08:16:00 |
S&P DJI Announces June 2020 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb35c2c528c0b3361021972efcf170ba |
|
2020-06-24 09:53:51 |
Resignation of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e7a5cb1ed8fc87b8955e1d4ce98b248 |
Appointment / Resignation
|
2020-06-26 16:11:21 |
Final Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd76caa77932a24367a5625bfc3371dd |
|
2020-06-26 18:02:57 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55e89182cb9c03868fb66928e969137b |
|
2020-07-03 08:47:28 |
Paradigm adds Dr Donna Skerrett as Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f511a542bf94b0b37c369078f47fd64 |
Appointment / Resignation
|
2020-07-07 17:57:52 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3e4490a79c8611881b05d53f83575ef |
|
2020-07-15 09:47:58 |
NEW FINANCIAL YEAR UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aea9c51895abceb95497ff1c8f191be3 |
Company Administration General
|
2020-07-17 16:42:28 |
Cleansing Notice and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07ebc76d51206bba05f5c9b544a182dd |
|
2020-07-29 16:04:40 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b21d99ebdab1ab8fc5b9c1e4761db33 |
|
2020-07-30 08:29:25 |
EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c01083193218218c0f8883c494c060fa |
|
2020-07-31 16:05:49 |
Quarterly Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/152e039357a766cc4edfdbed5da8cb40 |
|
2020-08-11 08:47:35 |
MPS RECEIVES CRITICAL APPROVALS AND FEEDBACK FROM AGENCIES |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c3b8f76d15303da2a7e4a402e935d5e |
|
2020-08-28 08:18:49 |
Appendix 4E and 2020 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a7ff40b758a88c67b61151ffccf0d2a |
|
2020-08-28 08:20:10 |
Appendix 4G and 2020 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d8a86c6754ab2a54ca9d22533b6e659 |
|
2020-09-17 08:23:36 |
Paradigm Presentation to Emerging Leaders Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15f53b035bdadae027642b239a24afd7 |
Company Administration General
|
2020-09-18 16:49:56 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e7a7f1734d0dbcde859285c9e21b085 |
|
2020-09-28 08:53:55 |
EMA PROVIDES KEY PATH TOWARD PHASE 3 TRIALS AND REGISTRATION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/845836d3e5dd4cc346a478fce0a63736 |
|
2020-09-29 08:22:47 |
EXTENSION OF EXCLUSIVE AGREEMENT WITH BENE PHARMACHEM |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8a5b519218d89708da849cbe16959c4 |
|
2020-10-01 09:06:25 |
ZILOSUL REDUCES PAIN IN PATIENTS WITH KNEE OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a87590cc0f15a8b1715ba1924b9d322 |
|
2020-10-13 08:15:29 |
PARADIGM ADDS MORE TALENTED SENIOR EXECUTIVES TO ITS TEAM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e573842ddbacfd74eb079c5e275ecd3 |
Company Administration General
|
2020-10-15 08:18:42 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76851e406012ce767d72e882eee92684 |
|
2020-10-30 12:50:39 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43e884107739033cb35a57048ac43bc3 |
|
2020-11-04 08:22:18 |
Paradigm to present at NWR Virtual Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7739aa7b43d1d02150ede8002a25887d |
|
2020-11-06 16:24:40 |
Ordinary Shares Cancellation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f293c72a3110c47f35a28559b04c231a |
|
2020-11-12 08:19:56 |
FIRST PATIENT DOSED IN MPS-I PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/62f4b5410ca3520f93d30dd7e2eebc31 |
|
2020-11-19 10:16:53 |
Paradigm AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7f026818d919f48263dcc8182eeac61 |
|
2020-11-19 15:23:05 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/714d8423902fe1b2b68288e0ad59e244 |
|
2020-11-20 08:14:20 |
Resignation of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c838236fcf52725ad09a875c3af4336 |
Appointment / Resignation
|
2020-11-20 16:40:12 |
Final Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b95f38aa3ba18f479e08b7e205d910cf |
|
2020-11-25 16:09:55 |
Cleansing Notice and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52747cf8521868049e31b3d1f980970a |
|
2020-12-01 12:36:28 |
Paradigm to Present at Evercore ISI HealthCONx Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db4bd6176b6bbfa5db0a3bba01604022 |
Company Administration General
|
2020-12-08 08:25:08 |
Paradigm to Host Inaugural R&D Day |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31d619962b912c1fc8ef28f10bd47dc3 |
Company Administration General
|
2020-12-09 08:20:45 |
Paradigm welcomes Amos Meltzer as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eec98ca547fc34d851ef6b5e3848506e |
Appointment / Resignation
|
2020-12-14 08:23:21 |
Paradigm Provides Phase 3 Clinical Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89e7c27e835544abe649247b0af46891 |
|
2020-12-15 18:23:36 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ca0011032228e094f35b4219d107dec |
|
2020-12-17 16:14:21 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ffd5f98f624c86f0be1e3e4b616fb23 |
|
2020-12-18 08:40:41 |
PARADIGM RECEIVES POSTIVE FEEDBACK FROM FDA TYPE C MEETING |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea653101e6d1c2c413b7d7a47899b342 |
|
2020-12-21 09:17:38 |
R&D Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/980cfacc531eae3c43a8051f54dd4d91 |
|
2021-01-06 08:23:20 |
Paradigm to present at the J.P. Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b3d8365b2ee30ed00954f18027c3907 |
Company Administration General
|
2021-01-12 17:33:57 |
39th Annual JP Morgan Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/309d7d341ff68df5543ae4867cc20732 |
|
2021-01-18 17:49:18 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69c8a4a12bc7bb815a813e32eced079a |
|
2021-01-18 17:50:08 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/504265afb67d283ef16ea3ffc6079885 |
|
2021-01-18 17:50:23 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ca5d6e5370b1a860d3f4ee5c1d5fa34 |
|
2021-01-21 17:27:36 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5d7ffb2357fd6f1d14f23cee2ebd6ab |
|
2021-01-29 08:22:59 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec78bdb52ff5029d6ffc215faf36edb4 |
|
2021-02-01 16:57:21 |
Statement pursuant to Listing Rule 4.7C.3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/229f830f6805d20c6027b2f4b38b37e3 |
Company Administration General
|
2021-02-03 08:18:32 |
Consistent pain reduction and improvement in function data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e6e9a6094fe8df04ee25ba70966bda3 |
|
2021-02-11 08:55:26 |
Paradigm Welcomes Helen Fisher as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4a4ea60143149f2f6a4685f45745ff3 |
Appointment / Resignation
|
2021-02-18 10:49:30 |
Ethics Approval Received for Synovial Fluid Biomarker Study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3932caf567d38a1812d844c2f3d05836 |
|
2021-02-23 08:54:32 |
Paradigm Receives $3.38m R&D Tax Incentive Refund |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11346766f15869ef3cbc9e7ea6496828 |
|
2021-02-24 12:13:16 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/131ffb679709371d3563c85d6632c7a0 |
|
2021-02-26 16:31:51 |
Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee211499e7bf3a4fd39777fdbf0bdef8 |
|
2021-03-18 09:05:28 |
PHASE 2 RRV DATA PUBBLISHED IN PEER-REVIEWED JOURNAL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5df1d84e32b94831418f73152fc00eb7 |
|
2021-03-26 09:40:25 |
Paradigm delivers IND to US FDA for Pivotal OA Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/551d06eba6348c960523c0176d9aca29 |
|
2021-03-31 08:31:02 |
Paradigm and Bene Execute New Collaboration Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ff7a3678741844e10000d9f950dfd24 |
|
2021-04-14 09:16:38 |
Paradigm doses first participant in Synovial Fluid Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb0aefa0061fbe594cddced5857bb9ba |
|
2021-04-15 16:25:08 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b22a40b637bcb673906f5cc4be0afdb3 |
|
2021-04-26 09:02:47 |
PARADIGM PROVIDES IND APPLICATION UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0731357b4af8cdc19fd5a447d5b625bf |
|
2021-04-30 08:32:07 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90c6b4099a7e88c3758d14744730d6dd |
|
2021-05-03 09:02:19 |
Paradigm to Present at Truist Securities Life Sciences Summi |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0705e019cbe593c2119c6dc6e8ffd7ea |
|
2021-05-13 17:10:18 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9de7c6623cdfa48bb5d0886c5005d9f |
|
2021-05-19 09:00:11 |
PARADIGM ACHIEVES FIRST REVENUE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbc525dcbe491e8886e7a97fbfbb860d |
|
2021-05-21 16:27:40 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa1873754c627936c5a62b30a59b1762 |
|
2021-05-25 08:23:54 |
IND QUESTIONS RECEIVED FROM US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9437be601a7dcd0dfba33a9f2b308eb9 |
|
2021-06-18 09:09:54 |
PARADIGM RECEIVES KEY REGULATORY APPROVALS FOR MPS VI STUDY |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e8836b2130f0b733b0f3dc907017afd |
|
2021-06-30 08:22:35 |
PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/812e0d54b3da3902519dda4a61fc5826 |
|
2021-07-09 18:17:53 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db4a039cd46e34be499bc8222f5acdbe |
|
2021-07-14 18:00:19 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d56c9b8ab0121fd233567d7b4d2a496 |
|
2021-07-19 09:35:02 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbf957a6a9044d8444abc847a52800b9 |
|
2021-07-29 08:58:45 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31bbda93a6e7911993074a9e1ad57d90 |
|
2021-07-30 08:55:23 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/09d6a5351fcbe435740d7933aa31c2d3 |
|
2021-08-03 08:55:57 |
PARADIGM REPORTS IND APPLICATION UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0f8128e1b1c64379b68f81315b9d0e5 |
Stock Exchange Announcement Ge
|
2021-08-27 08:33:48 |
2021 Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d851fd81deb490fa54c4f4318c229ef |
|
2021-08-27 08:34:43 |
Appendix 4G and 2021 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc6c8c42fa3654261a3322b847ed0cf0 |
|
2021-09-13 08:22:49 |
CHIKV study data published in Peer-Reviewed Journal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16994bb2a11dd2bef6a1c558cc789535 |
|
2021-09-17 16:30:33 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1527bc53f9215d39deedaf532d3b5e98 |
|
2021-09-17 16:33:39 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7a35a961380d0ed7c8448e8a14e5535 |
|
2021-09-24 08:31:46 |
AUS ETHICS APPROVAL RECEIVED FOR PHASE 3 TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ed0b0834be2c9c99a73d73fb8a9f5d6d |
|
2021-09-27 08:23:30 |
PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02ab5831319ed5bed5dd829a16529f82 |
|
2021-09-30 10:34:05 |
FIRST MPS-VI PATIENT DOSED UNDER PHASE 2 TRIAL IN BRAZIL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b336d5fe79d9b7a2518fe56dcc22a9e6 |
|
2021-10-13 08:29:42 |
POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3e1c2879f075ea6cfd05347ca28ea39 |
|
2021-10-26 09:21:43 |
Phase 2 Synovial Fluid Biomarker Study Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6adcffb51b871809e92b35e86dba12a3 |
|
2021-10-28 08:53:31 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eb46c6929768ca5a24213a9497a0b328 |
|
2021-10-29 08:32:34 |
Date of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3105eedba9c18cbd38babd9e18ddf3b |
|
2021-11-01 08:38:06 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d4b59df8e337d7f3d382268fb5927fd |
|
2021-11-03 08:45:34 |
PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e95a7eeb4a6d2c34e55273c5fc7f592 |
Company Administration General
Stock Exchange Announcement Ge
|
2021-11-08 08:59:06 |
Global Market Research indicates price for Zilosu |
0 |
https://app.sharelinktechnologies.com/announcement/asx/335fe2e75d961c753e25c5c302f9936e |
Company Administration General
|
2021-11-09 09:28:45 |
Paradigm Presentation to Bell Potter Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b632dd8fb95295812700c3548671e06c |
|
2021-11-11 16:18:45 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/615222e9f290ac093cf4b694734c51d7 |
|
2021-11-18 08:22:18 |
Paradigm welcomes Dr Reiter from bene pharmaChem to the team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03cd7f4262ffaa5223d9f8f47782872d |
Company Administration General
|
2021-11-22 08:46:25 |
Paradigm CEO Paul Rennie to transition to Non-Exec Chairman |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fed2184304a9505a9af85fef13c80c37 |
Company Administration General
|
2021-11-23 08:37:47 |
Preliminary Results from Phase 2 MPS I Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49493cb766fd91a6c63ca32e2094d4a9 |
|
2021-11-24 16:30:17 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a812683e2a43f9562abc539a292fe8fe |
|
2021-11-30 09:36:55 |
Paradigm Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cafef8dd5cd154705fa69e8d50677d4b |
|
2021-12-02 10:03:15 |
Paradigm Presentation for Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f4c128f5d8aeafe282b6eb018b5f3b2 |
|
2021-12-16 12:29:58 |
PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1356774292e1726eaafc26e34d472ef5 |
|
2021-12-24 08:23:05 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65eddc6ab9852fe3e937385307138ec2 |
|
2022-01-12 16:34:06 |
Paradigm to present at the J.P Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec212cd3d83b50cf22076fae14ee6ced |
|
2022-01-13 08:29:46 |
PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40659b260859f2c81c52200ee20aa2e1 |
|
2022-01-25 09:31:15 |
Paradigm AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01c9720ed8a65ba03751e64cafde70e8 |
|
2022-01-25 15:35:07 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c4e052e41d3cbbecf8e0bd7cdf3e2d1 |
|
2022-01-31 15:15:03 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/675b7b6690c66dee87cec21ad44e12e1 |
|
2022-02-01 16:07:36 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b7bc5caa58c939303393a8aa38f8c01 |
|
2022-02-01 16:09:26 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f157a663146978f935978950bbf051e5 |
|
2022-02-01 16:11:21 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c8d6e236c0b15c9a3740d8bc699262c |
|
2022-02-11 10:04:06 |
PPS a new adjunct therapy treatment for patients with MPS VI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4662c493e1c4866411a0bd927fc0f698 |
|
2022-02-24 09:47:20 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0317e44c424d39481e02317b7cdd4818 |
|
2022-02-24 10:15:05 |
Paradigm 1HY22 Key Activity Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/276d6ef46d009e8ddfec270dfef36e8b |
|
2022-02-24 12:03:10 |
Amended Appendix 4D |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4759be030b522fb3cda9d3a05f6f6820 |
|
2022-03-04 17:02:11 |
S&P DJI Announces March 2022 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1f989b653b9b7b5ff18db45a6d18ddd7 |
|
2022-03-09 10:54:34 |
Clarification of recent analyst report on Patent Protection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3e9de0df8f3cdc4d59c435c96870021 |
|
2022-03-09 16:13:55 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44a185c751c2bf40d71fbe6ba9db4550 |
|
2022-03-09 16:14:25 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85a77107bbb1b6831bf3603a333bf5f5 |
|
2022-03-17 09:20:19 |
UK ethics and regulatory approval for Phase 3 study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7029ee5ba1a78cb773bf2a246510b333 |
|
2022-04-12 11:38:42 |
FDA Grants Paradigm Fast Track Designation For OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a9a566b308c87621769224c498ec7ea |
|
2022-04-28 09:50:52 |
Paradigm Doses First US Subjects under Phase 3 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ad8adf2628ba24b3f5333a520115d40 |
|
2022-04-29 08:42:13 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/101baed7541d48c4fb67b085468931bc |
|
2022-05-30 08:23:50 |
Paradigm Appoints Experienced US-Based CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dcf5f67a9671a6ff825cf27efcf306f4 |
Company Administration General
Appointment / Resignation
|
2022-06-07 08:23:26 |
Paradigm Receives $8.2m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70f274c8cd3e2cc32456971b6207b588 |
|
2022-06-29 16:15:21 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0161509b620d17f9a5ba7baab5f5bb06 |
|
2022-06-30 08:24:56 |
Paradigm Reports Australian Patent Acceptance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9395426ffc9928b889c80690696aedb6 |
|
2022-07-01 08:30:58 |
100% Recruitment in Synovial Fluid Biomarker Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51877b2cba6d798678115439ec9029ab |
|